High prevalence and inferior long-term outcomes for TP53 mutations in therapy-related acute lymphoblastic leukemia.
Hoda Z PourhassanDongyun YangMichelle AfkhamiRaju PillaiBrian J BallMonzr M Al MalkiAmandeep SalhotraHaris AliAndrew ArtzPeter CurtinSaro ArmenianAnthony SteinStephen J FormanGuido MarcucciVinod A PullarkatRyotaro NakamuraIbrahim AldossPublished in: American journal of hematology (2022)